Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

TCR V beta 8.1/2 Antikörper

Der Ratte Monoklonal anti-TCR V beta 8.1/2 Antikörper wird verwendet zum Nachweis von TCR V beta 8.1/2 in Proben von Maus. Er wurde validiert für FACS.
Produktnummer ABIN8062751
204,00 €
Zzgl. Versandkosten 20,00 € und MwSt
Lieferung nach: Deutschland
Lieferung in 9 bis 13 Werktagen

Kurzübersicht für TCR V beta 8.1/2 Antikörper (ABIN8062751)

Target

TCR V beta 8.1/2

Reaktivität

Maus

Wirt

  • 1
  • 1
Ratte

Klonalität

  • 2
Monoklonal

Konjugat

  • 1
  • 1
Unkonjugiert

Applikation

  • 2
  • 1
  • 1
Flow Cytometry (FACS)

Klon

KJ16-133-18
  • Verwendungszweck

    Purified Anti-Mouse TCR V beta8.1/2 Antibody[KJ16-133.18]

    Isotyp

    IgG2a, kappa
  • Applikationshinweise

    Optimal working dilution should be determined by the investigator.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Konzentration

    ≥ 1 mg/mL

    Buffer

    Phosphate buffered solution, pH 7.2, containing 0.05 % proclin 300.

    Konservierungsmittel

    ProClin

    Vorsichtsmaßnahmen

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Handhabung

    avoid freeze / thaw cycles.

    Lagerung

    4 °C,-20 °C

    Informationen zur Lagerung

    Store at 4°C valid for 12 months or -20°C valid for long term storage, avoid freeze / thaw cycles.

    Haltbarkeit

    12 months
  • Target

    TCR V beta 8.1/2

    Hintergrund

    The ability of T cell receptors (TCR) to discriminate foreign from self-peptides presented by major histocompatibility complex (MHC) class II molecules is essential for an effective adaptive immune response. TCR recognition of self-peptides has been linked to autoimmune disease. Mutant self-peptides have been associated with tumors. Engagement of TCRs by a family of bacterial toxins know as superantigens has been responsible for toxic shock syndrome. Autoantibodies to V beta segments of T cell receptors have been isolated from patients with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). The autoantibodies block TH1-mediated inflammatory autodestructive reactions and are believed to be a method by which the immune system compensates for disease. Most human T cells express the TCR alpha-beta and either CD4 or CD8 Molecule (single positive, SP). A small number of T cells lack both CD4 and CD8 (double negative, DN). Increased percentages of alpha-beta DN T cells have been identified in some autoimmune and immunodeficiency disorders. Gamma-delta T cells are primarily found within the epithelium. They show less TCR diversity and recognize antigens differently than alpha-beta T cells. Subsets of gamma-delta T cells have shown antitumor and immunoregulatory activity.
Sie sind hier:
Chat with us!